BE485075A - - Google Patents
Info
- Publication number
- BE485075A BE485075A BE485075DA BE485075A BE 485075 A BE485075 A BE 485075A BE 485075D A BE485075D A BE 485075DA BE 485075 A BE485075 A BE 485075A
- Authority
- BE
- Belgium
- Prior art keywords
- solution
- suspension
- gases
- inactive gases
- inactive
- Prior art date
Links
- 239000000725 suspension Substances 0.000 claims description 12
- 239000007789 gas Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 5
- 229930003231 vitamin Natural products 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 230000000694 effects Effects 0.000 claims description 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims 2
- 238000004321 preservation Methods 0.000 claims 1
- 239000000243 solution Substances 0.000 description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- -1 vitamins D Natural products 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B3/00—Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
- B65B3/003—Filling medical containers such as ampoules, vials, syringes or the like
Landscapes
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE485075A true BE485075A (enExample) |
Family
ID=131088
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE485075D BE485075A (enExample) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE485075A (enExample) |
-
0
- BE BE485075D patent/BE485075A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1446373B1 (fr) | Procede de preparation d'une composition contenant au moins un produit de deshydratation interne d'un sucre hydrogene | |
| US20090035387A1 (en) | Process for making ozonized olive oil gel and the gel obtained | |
| DeMaster et al. | Mechanism for the inhibition of aldehyde dehydrogenase by nitric oxide | |
| FR2532849A1 (fr) | Composition pharmaceutique solide contenant des antibiotiques b-lactamiques, son procede de preparation et procede pour stabiliser une composition pharmaceutique | |
| US4900336A (en) | Method of preferentially removing oxygen from ozonated water | |
| Paco et al. | Catalase‐like activity of bovine met‐hemoglobin: Interaction with the pseudo‐catalytic peroxidation of anthracene traces in aqueous medium | |
| AU751240B2 (en) | Therapies using hemoproteins | |
| CA1080464A (en) | Process for the continuous preparation of percarboxylic acids in organic solutions | |
| EP0032872B1 (fr) | Procédé d'obtention d'un moyen thérapeutique, sous forme gazeuse, et moyen thérapeutique ainsi obtenu | |
| EP0228957A1 (fr) | Procédé d'extraction de composés organiques de leurs solutions ou suspensions aqueuses | |
| FR2880807A1 (fr) | Composition pharmaceutique injectable | |
| CH327118A (fr) | Procédé de préparation d'une suspension aqueuse d'un sel de pénicilline | |
| Pietraforte et al. | Formation of an adduct by clenbuterol, a β-adrenoceptor agonist drug, and serum albumin in human saliva at the acidic pH of the stomach: Evidence for an aryl radical-based process | |
| BE358835A (enExample) | ||
| BE446867A (enExample) | ||
| BE469299A (enExample) | ||
| US3478092A (en) | Method of improving the color and color stability of benzoic acid | |
| FR2648147A1 (fr) | Procede pour la preparation de beta-monoglycerides et produits obtenus | |
| BE392920A (enExample) | ||
| BE447307A (enExample) | ||
| FR2579075A1 (fr) | Procede de decoloration de sang et de cruor animal et produit obtenu | |
| LU85416A1 (fr) | Composition solide d'engrais complexe organo-mineral et son procede de preparation | |
| BE522518A (enExample) | ||
| BE505594A (enExample) | ||
| Boring et al. | Drug interactions I: Detection of inorganic nitrite in organic nitrate esters under acidic conditions simulating the human stomach |